To determine the genetic risk factors for venous thromboembolism (VTE), this study examined 14 genetic variants from 10 hemostatic genes in 186 Taiwanese VTE patients and the same number of matched controls, which demonstrated FGA (encoding alpha fibrinogen) Thr312Ala polymorphism was the only variant significantly associated with VTE. Nine genetic polymorphisms on the fibrinogen cluster region of chromosome 4q28 were further studied, in which four FGA polymorphisms were found in strong linkage disequilibrium and were significantly associated with VTE by genotype and allele frequency analyses. Haplotype analysis showed significantly different FGA haplotype frequencies between VTE patients and controls with the haplotype F1, containing -1051...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer. Homozygous carriers...
The role of the A>G polymorphism at position 19911 in the prothrombin gene (factor [F] 2 at rs313...
Carriership of the factor V (FV) Leiden mutation increases the risk of venous thromboembolism (VTE) ...
International audienceINTRODUCTION: Fibrinogen Aalpha-Thr312Ala and Factor XIII Val34Leu polymorphis...
International audienceVenous thromboembolism (VTE) is a multifactorial disease, caused by interactin...
The α-fibrinogen Thr312Ala variant has been shown to influence clot structure through increased fact...
Venous thrombosis is a major medical disorder caused by both genetic and environmental factors. Litt...
A number of single nucleotide polymorphisms (SNP) have been linked to higher risk of venous thromboe...
Haplotypes of the fibrinogen gamma and alpha (FGG and FGA) genes are associated with the structure o...
Previous genome-wide association studies (GWASs) have established several susceptibility genes for v...
Venous thromboembolism (VTE) is a common, heritable disease resulting in high rates of hospitalizati...
IntroductionEpidemiological studies generally have not found plasma total fibrinogen to be a risk fa...
Objective of our study is to determine whether decreased fibrinolytic activity or plasminogen activa...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer. Homozygous carriers...
The role of the A>G polymorphism at position 19911 in the prothrombin gene (factor [F] 2 at rs313...
Carriership of the factor V (FV) Leiden mutation increases the risk of venous thromboembolism (VTE) ...
International audienceINTRODUCTION: Fibrinogen Aalpha-Thr312Ala and Factor XIII Val34Leu polymorphis...
International audienceVenous thromboembolism (VTE) is a multifactorial disease, caused by interactin...
The α-fibrinogen Thr312Ala variant has been shown to influence clot structure through increased fact...
Venous thrombosis is a major medical disorder caused by both genetic and environmental factors. Litt...
A number of single nucleotide polymorphisms (SNP) have been linked to higher risk of venous thromboe...
Haplotypes of the fibrinogen gamma and alpha (FGG and FGA) genes are associated with the structure o...
Previous genome-wide association studies (GWASs) have established several susceptibility genes for v...
Venous thromboembolism (VTE) is a common, heritable disease resulting in high rates of hospitalizati...
IntroductionEpidemiological studies generally have not found plasma total fibrinogen to be a risk fa...
Objective of our study is to determine whether decreased fibrinolytic activity or plasminogen activa...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer. Homozygous carriers...
The role of the A>G polymorphism at position 19911 in the prothrombin gene (factor [F] 2 at rs313...
Carriership of the factor V (FV) Leiden mutation increases the risk of venous thromboembolism (VTE) ...